Overview

Mildronate for Acute Ischemic Stroke

Status:
Completed

Trial end date:
2010-04-01

Target enrollment:

Participant gender:

Summary

Mildronate an inhibitor of carnitine-dependent metabolism, is considered an anti-ischemic drug. This study aims to evaluate the efficacy and safety of mildronate injection in treating acute ischemic stroke.

Phase:

Phase 2

Details

Lead Sponsor:

Xijing Hospital

Treatments:

3-(2,2,2-trimethylhydrazine)propionate
Aspirin
Cinepazide
Maleic acid